Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users

Psychiatry Research - Neuroimaging

Volumn 174, Issue 1, 2009, Pages 1-8

  Alicata, Daniel ^a   Chang, Linda ^a   Cloak, Christine ^a   Abe, Kylie ^a   Ernst, Thomas ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Apparent diffusion coefficient; Basal ganglia; Diffusion tensor imaging; Frontal lobe; MRI

Indexed keywords

METHAMPHETAMINE;

ADULT; ANISOTROPY; ARTICLE; AXONAL INJURY; BASAL GANGLION; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DRUG DEPENDENCE; FEMALE; FRONTAL LOBE; HUMAN; INFLAMMATION; MALE; MYELINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PUTAMEN; WHITE MATTER;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANISOTROPY; BASAL GANGLIA; BRAIN MAPPING; CASE-CONTROL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NERVE FIBERS, MYELINATED; YOUNG ADULT;

EID: 71749088317     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2009.03.011     Document Type: Article

References (51)

1. Alexander A.L., Lee J.E., Lazar M., and Field A.S. Diffusion tensor imaging of the brain. Neurotherapeutics 4 (2007) 316-329
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (2000), American Psychiatric Press, Washington, DC
3. Bae S.C., Lyoo I.K., Sung Y.H., Yoo J., Chung A., Yoon S.J., Kim D.J., Hwang J., Kim S.J., and Renshaw P.F. Increased white matter hyperintensities in male methamphetamine abusers. Drug and Alcohol Dependence 81 (2006) 83-88
4. Berman S., O'Neill J., Fears S., Bartzokis G., and London E.D. Abuse of amphetamines and structural abnormalities in the brain. Annals of the New York Academy of Sciences 1141 (2008) 195-220
5. Bhagat Y.A., and Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression. Journal of Magnetic Resonance Imaging 20 (2004) 216-227
6. Brody A.L., Mandelkern M.A., Jarvik M.E., Lee G.S., Smith E.C., Huang J.C., Bota R.G., Bartzokis G., and London E.D. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biological Psychiatry 55 (2004) 77-84
7. Chang L., Cloak C., Patterson K., Grob C., Miller E.N., and Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biological Psychiatry 57 (2005) 967-974
8. Chang L., Ernst T., Speck O., and Grob C.S. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. American Journal of Psychiatry 162 (2005) 361-369
9. Chang L., Alicata D., Ernst T., and Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 Suppl 1 (2007) 16-32
10. Chung A., Lyoo I.K., Kim S.J., Hwang J., Bae S.C., Sung Y.H., Sim M.E., Song I.C., Kim J., Chang K.H., and Renshaw P.F. Decreased frontal white-matter integrity in abstinent methamphetamine abusers. International Journal of Neuropsychopharmacology 10 (2007) 765-775
11. Elkashef A.M., Rawson R.A., Anderson A.L., Li S.H., Holmes T., Smith E.V., Chiang N., Kahn R., Vocci F., Ling W., Pearce V.J., McCann M., Campbell J., Gorodetzky C., Haning W., Carlton B., Mawhinney J., and Weis D. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 33 (2007) 1162-1170
12. Ernst T., Chang L., Leonido-Yee M., and Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54 (2000) 1344-1349
13. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and Hanson G.R. New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology 47 (2007) 681-698
14. Gallinat J., Meisenzahl E., Jacobsen L.K., Kalus P., Bierbrauer J., Kienast T., Witthaus H., Leopold K., Seifert F., Schubert F., and Staedtgen M. Smoking and structural brain deficits: a volumetric MR investigation. European Journal of Neuroscience 24 (2006) 1744-1750
15. Harvey D.C., Lacan G., Tanious S.P., and Melega W.P. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Research 871 (2000) 259-270
16. Iritani B.J., Hallfors D.D., and Bauer D.J. Crystal methamphetamine use among young adults in the USA. Addiction 102 (2007) 1102-1113
17. Irwan R., Sijens P.E., Potze J.H., and Oudkerk M. Correlation of proton MR spectroscopy and diffusion tensor imaging. Magnetic Resonance Imaging 23 (2005) 851-858
18. Jacobsen L.K., Picciotto M.R., Heath C.J., Frost S.J., Tsou K.A., Dwan R.A., Jackowski M.P., Constable R.T., and Mencl W.E. Prenatal and adolescent exposure to tobacco smoke modulates the development of white matter microstructure. Journal of Neuroscience 27 (2007) 13491-13498
19. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.D., Heaton R.K., Ellis R.J., and Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. American Journal of Psychiatry 162 (2005) 1461-1472
20. Jiang H., van Zijl P.C., Kim J., Pearlson G.D., and Mori S. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Computer Methods and Programs in Biomedicine 81 (2006) 106-116
21. Kim S.J., Lyoo I.K., Hwang J., Sung Y.H., Lee H.Y., Lee D.S., Jeong D.U., and Renshaw P.F. Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 30 (2005) 1383-1391
22. Kim S.J., Lyoo I.K., Hwang J., Chung A., Hoon Sung Y., Kim J., Kwon D.H., Chang K.H., and Renshaw P.F. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. International Journal of Neuropsychopharmacology 9 (2006) 221-228
23. Kim I.S., Kim Y.T., Song H.J., Lee J.J., Kwon D.H., Lee H.J., Kim M.N., Yoo D.S., and Chang Y. Reduced corpus callosum white matter microstructural integrity revealed by diffusion tensor eigenvalues in abstinent methamphetamine addicts. Neurotoxicology 30 (2009) 209-213
24. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., and Chabriat H. Diffusion tensor imaging: concepts and applications. Journal of Magnetic Resonance Imaging 13 (2001) 534-546
25. Lim K.O., Choi S.J., Pomara N., Wolkin A., and Rotrosen J.P. Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biological Psychiatry 51 (2002) 890-895
26. Lim K.O., Wozniak J.R., Mueller B.A., Franc D.T., Specker S.M., Rodriguez C.P., Silverman A.B., and Rotrosen J.P. Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug and Alcohol Dependence 92 (2008) 164-172
27. Moeller F.G., Hasan K.M., Steinberg J.L., Kramer L.A., Dougherty D.M., Santos R.M., Valdes I., Swann A.C., Barratt E.S., and Narayana P.A. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 30 (2005) 610-617
28. Moeller F.G., Hasan K.M., Steinberg J.L., Kramer L.A., Valdes I., Lai L.Y., Swann A.C., and Narayana P.A. Diffusion tensor imaging eigenvalues: preliminary evidence for altered myelin in cocaine dependence. Psychiatry Research: Neuroimaging 154 (2007) 253-258
29. Moeller F.G., Steinberg J.L., Lane S.D., Buzby M., Swann A.C., Hasan K.M., Kramer L.A., and Narayana P.A. Diffusion tensor imaging in MDMA users and controls: association with decision making. American Journal of Drug and Alcohol Abuse 33 (2007) 777-789
30. Moszczynska A., Fitzmaurice P., Ang L., Kalasinsky K.S., Schmunk G.A., Peretti F.J., Aiken S.S., Wickham D.J., and Kish S.J. Why is parkinsonism not a feature of human methamphetamine users?. Brain 127 (2004) 363-370
31. Nordahl T.E., Salo R., Possin K., Gibson D.R., Flynn N., Leamon M., Galloway G.P., Pfefferbaum A., Spielman D.M., Adalsteinsson E., and Sullivan E.V. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Psychiatry Research: Neuroimaging 116 (2002) 43-52
32. Pfefferbaum A., Adalsteinsson E., Rohlfing T., and Sullivan E.V. Diffusion tensor imaging of deep gray matter brain structures: effects of age and iron concentration. Neurobiology of Aging (2008) 10.1016/J.Neurobiolaging.2008.04.013
33. Rose J.E., Behm F.M., Westman E.C., Mathew R.J., London E.D., Hawk T.C., Turkington T.G., and Coleman R.E. PET studies of the influences of nicotine on neural systems in cigarette smokers. American Journal of Psychiatry 160 (2003) 323-333
34. Salo R., Nordahl T.E., Natsuaki Y., Leamon M.H., Galloway G.P., Waters C., Moore C.D., and Buonocore M.H. Attentional control and brain metabolite levels in methamphetamine abusers. Biological Psychiatry 61 (2007) 1272-1280
35. Salo R., Nordahl T.E., Buonocore M.H., Natsuaki Y., Waters C., Moore C.D., Galloway G.P., and Leamon M.H. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study. Biological Psychiatry 65 (2009) 122-128
36. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N., and Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry 158 (2001) 1206-1214
37. Sekine Y., Minabe Y., Kawai M., Suzuki K., Iyo M., Isoda H., Sakahara H., Ashby Jr. C.R., Takei N., and Mori N. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study. Neuropsychopharmacology 27 (2002) 453-461
38. Sekine Y., Ouchi Y., Takei N., Yoshikawa E., Nakamura K., Futatsubashi M., Okada H., Minabe Y., Suzuki K., Iwata Y., Tsuchiya K.J., Tsukada H., Iyo M., and Mori N. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry 63 (2006) 90-100
39. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., Iwata Y., Tsuchiya K.J., Suda S., Suzuki K., Kawai M., Takebayashi K., Yamamoto S., Matsuzaki H., Ueki T., Mori N., Gold M.S., and Cadet J.L. Methamphetamine causes microglial activation in the brains of human abusers. Journal of Neuroscience 28 (2008) 5756-5761
40. Substance Abuse and Mental Health Services Administration (2007). Results from the 2006 national survey on drug use and health: national findings. DHHS Publication No. SMA 07-4293, NSDUH Series H-32, Rockville, MD. Office of Applied Studies, Substance Abuse and Mental Health Services Administration.
41. Sung Y.H., Cho S.C., Hwang J., Kim S.J., Kim H., Bae S., Kim N., Chang K.H., Daniels M., Renshaw P.F., and Lyoo I.K. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug and Alcohol Dependence 88 (2007) 28-35
42. Tang C.Y., Friedman J., Shungu D., Chang L., Ernst T., Stewart D., Hajianpour A., Carpenter D., Ng J., Mao X., Hof P.R., Buchsbaum M.S., Davis K., and Gorman J.M. Correlations between diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (1H MRS) in schizophrenic patients and normal controls. BioMed Central Psychiatry 7 (2007) 25
43. Thomas D.M., and Kuhn D.M. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. Journal of Neurochemistry 92 (2005) 790-797
44. Thomas D.M., Walker P.D., Benjamins J.A., Geddes T.J., and Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. Journal of Pharmacology And Experimental Therapeutics 311 (2004) 1-7
45. Thomas D.M., Francescutti-Verbeem D.M., and Kuhn D.M. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. Journal of Neurochemistry 105 (2007) 605-616
46. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., and London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience 24 (2004) 6028-6036
47. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., and Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience 21 (2001) 9414-9418
48. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Wong C., and Logan J. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. American Journal of Psychiatry 158 (2001) 383-389
49. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Logan J., Wong C., and Miller E.N. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry 158 (2001) 377-382
50. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., and Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine 2 (1996) 699-703
51. Yamamoto B.K., and Bankson M.G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Critical Reviews in Neurobiology 17 (2005) 87-117